Contacts

Partner with Anabion

We collaborate with global CDMO service providers for the development and manufacturing of biopharmaceuticals

About Partnership
Impact

Technological platforms

and experience to develop mAbs, ADCs and recombinant proteins

Impact

High quality solutions

or biomanufacturing needs and technology scale-up

Impact

Comprehensive support

with the product at non-clinical, clinical and commercial stages

Our strategic
partnerships:

  • End-to-end support from non-clinical to commercial stages
  • Access to platforms for monoclonal antibodies, bispecifics, ADCs, and recombinant proteins
Let’s build the future
Let’s build the future
Impact

BIOCAD

(Russia):

Development and manufacturing of innovative biologics

Impact

MabPlex

(China):

Contract development and manufacturing services for antibodies

Impact

Intellective Bio

(China):

Biopharmaceutical CDMO with integrated R&D platforms

  • End-to-end support from non-clinical to commercial stages
  • Access to platforms for monoclonal antibodies, bispecifics, ADCs, and recombinant proteins

Let’s build the future
of medicine together

Let’s build
the future
of medicine together

We’re open to new global collaborations in distribution,
co-promotion, licensing, and joint R&D.

Our flexible business models are tailored to your market needs, including licensing,
co-promotion, and tech transfer.

Contacts